A biopharmaceutical company focused on developing a portfolio of internally discovered product candidates that utilize the body's natural nutrient transporter mechanisms to improve the therapeutic benefits of drugs.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
Getting restless for a long - playing an anticipated FDA pop in February. Long at $18.82
Holy cow! By pop, I guess you were referring to my head when I saw -65% this morning.....
Holy cow! By pop, I guess you were referring to my head when I saw -65% this morning.....
The FDA makes Vegas in the 1950's look like a clean racket. I simply have no predictive accuracy when it comes to these trials.
A horrible pick
Several top players entered thumbs up picks on XNPT yesterday and are already up 25%, guess it's all in the timing :-).
That's really the most logical way to play these stock - wait for the FDA to reject something and then pick the stock up when it trades near net cash - ugh
I would look for insider purchases and I pick a lot to spread the risk. In all, the index is going to have log-linear growth, even counting the inevitable decline of most post-one-hit-wonders in the index.